Farmer C, Petitclerc D
Agriculture and Agri-Food Canada, Dairy and Swine Research and Development Centre, Lennoxville, Québec J1M 1Z3, Canada.
J Anim Sci. 2003 Jul;81(7):1823-9. doi: 10.2527/2003.8171823x.
Prolactin is required from d 70 to 110 of gestation for normal mammary development of gilts. The goal of the present study was to determine the effect of inhibiting prolactin with bromocriptine during specific time windows during the second half of gestation on mammary gland development in gilts. Crossbred primigravid gilts were assigned as controls (n = 12) or received 10 mg of bromocriptine orally three times daily from d 50 to 69 (BR50, n = 12), d 70 to 89 (BR70, n = 12), or d 90 to 109 (BR90, n = 12) of gestation. Jugular blood samples were collected on d 50, 70, 90, and 109 of gestation and assayed for prolactin and estradiol. Gilts were slaughtered on d 109 of gestation and fetuses were counted and weighed. One row of mammary glands was used for dissection of parenchymal and extraparenchymal tissues, and for biochemical analyses. Tissue from the other row was used for measures of prolactin receptor number and affinity. Concentrations of prolactin were decreased markedly (P < 0.001) at the end of each bromocriptine treatment period compared with controls, but there was no overall treatment effect (P > 0.1) on estradiol concentrations. Extraparenchymal tissue weight of the mammary glands was unaffected by treatments (P > 0.1), but weight of parenchymal tissue, total DNA, and total RNA were lower (P < 0.01) in BR90 than control gilts. The percentage of DM in parenchymal tissue was unaffected by treatments (P > 0.1), but percentage of fat was higher and percentage of protein lower (P < 0.01) in BR90 gilts compared with controls. Cell size, as estimated by the protein:DNA ratio, also was lower (P < 0.01) in the BR90 group. Number and affinity of prolactin receptors in parenchymal tissue were not significantly altered by treatments. In conclusion, there is a specific time period in the second half of gestation, from 90 to 109 d, during which prolactin is essential for normal mammary parenchymal tissue development.
妊娠70至110天期间,催乳素是后备母猪正常乳腺发育所必需的。本研究的目的是确定在妊娠后半期的特定时间窗内用溴隐亭抑制催乳素对后备母猪乳腺发育的影响。将杂交初产后备母猪分为对照组(n = 12),或在妊娠50至69天(BR50,n = 12)、70至89天(BR70,n = 12)或90至109天(BR90,n = 12)期间每天口服3次10 mg溴隐亭。在妊娠50、70、90和109天采集颈静脉血样,检测催乳素和雌二醇。在妊娠109天屠宰后备母猪,统计并称重胎儿。一排乳腺用于实质组织和实质外组织的解剖以及生化分析。另一排的组织用于测量催乳素受体数量和亲和力。与对照组相比,每个溴隐亭治疗期结束时催乳素浓度显著降低(P < 0.001),但对雌二醇浓度没有总体治疗效果(P > 0.1)。乳腺实质外组织重量不受治疗影响(P > 0.1),但BR90组的实质组织重量、总DNA和总RNA低于对照组(P < 0.01)。实质组织中干物质百分比不受治疗影响(P > 0.1),但与对照组相比,BR90组后备母猪的脂肪百分比更高,蛋白质百分比更低(P < 0.01)。根据蛋白质:DNA比率估算的细胞大小在BR90组中也较低(P < 0.01)。治疗对实质组织中催乳素受体的数量和亲和力没有显著影响。总之,在妊娠后半期有一个特定时间段,即90至109天,在此期间催乳素对正常乳腺实质组织发育至关重要。